Background
Sepsis reduces neutrophil apoptosis. As the result, neutrophils may become aged, exacerbating inflammation and tissue injury. Extracellular cold-inducible RNA-binding protein (eCIRP) acts as a damage-associated molecular pattern to promote inflammation and tissue injury in sepsis. SerpinB2, a serine protease inhibitor, has been shown to inhibit apoptosis. We hypothesize that eCIRP upregulates SerpinB2 to promote aged neutrophil subset by inhibiting apoptosis in sepsis.
Methods
We stimulated bone marrow-derived neutrophils (BMDNs) of wild-type (WT) mice with 1 μg/mL of recombinant mouse CIRP (i.e., eCIRP) and assessed cleaved caspase-3 and SerpinB2 by Western blotting. Apoptotic neutrophils were assessed by Annexin V/PI. BMDNs were stimulated with 1 μg/mL eCIRP and treated with or without PAC-1 (caspase-3 activator) and aged neutrophils (CXCR4hiCD62Llo) were assessed by flow cytometry. To induce sepsis, we performed cecal ligation and puncture (CLP) in WT or CIRP-/- mice. We determined the percentage of aged neutrophils and SerpinB2+ neutrophils in blood and spleen by flow cytometry.
Results
We found that cleaved caspase-3 levels were increased at 4 h of PBS treatment compared to 0 h, but decreased by eCIR P treatment. eCIRP reduced apoptotic cells after 20 h of treatment. eCIRP also increased the frequencies of aged neutrophils compared to PBS after 20 h, while PAC-1 treatment reduced aging in eCIRP-treated BMDNs. eCIRP significantly increased the expression of SerpinB2 at protein levels in BMDNs at 20 h. In WT mice, the frequencies of aged and SerpinB2+ neutrophils in blood and spleen were increased after 20 h of CLP, while in CIRP-/- mice, aged and SerpinB2+ neutrophils were significantly decreased compared to WT mice. We also found that aged neutrophils expressed significantly higher levels of SerpinB2 compared to non-aged neutrophils.
Conclusions
eCIRP inhibits neutrophil apoptosis to increase aged phenotype by increasing SerpinB2 expression in sepsis. Thus, targeting eCIRP could be a new therapeutic strategy to ameliorate inflammation caused by neutrophil aging in sepsis.